» Articles » PMID: 18334868

Correlation Between Oesophageal Acid Exposure and Dyspeptic Symptoms in Patients with Nonerosive Reflux Disease

Overview
Specialty Gastroenterology
Date 2008 Mar 13
PMID 18334868
Citations 7
Authors
Affiliations
Soon will be listed here.
Abstract

Background & Aims: Oesophageal acidification induces dyspeptic symptoms in healthy individuals. This study aimed to evaluate the correlation between oesophageal acid exposure and dyspeptic symptoms in patients with nonerosive reflux disease.

Methods: A total of 68 patients with dominant symptoms of heartburn, negative upper gastrointestinal endoscopy and concomitant dyspeptic symptoms participated in the study. The severity of dyspepsia and reflux-related symptoms was evaluated, and 24-h gastro-oesophageal pH-monitoring study was performed in all patients at baseline and after 4 weeks of therapy with esomeprazole 40 mg.

Results: Oesophageal basal acid exposure was pathological in 43 patients and normal in 25 patients, with a similar prevalence and severity of individual dyspeptic symptoms in the two groups. A significant correlation between reflux and dyspepsia scores was observed in the subgroup of patients with normal, but not in those with abnormal pHmetry (r=0.4, P=0.04 and r=0.2 P=0.07, respectively). After esomeprazole, a reduction in severity of dyspepsia (>or=50% with respect to baseline) was observed, independent of improvement of reflux-associated symptoms. Improvement in dyspepsia was, however, similar in patients with normal and abnormal basal acid exposure (14/25 vs. 33/43, respectively, P=NS).

Conclusion: Dyspeptic symptoms coexist in a subset of nonerosive reflux disease patients, but prevalence and severity of the symptoms seems to be independent of oesophageal acid exposure.

Citing Articles

Specific dyspeptic symptoms are associated with poor response to therapy in patients with gastroesophageal reflux disease.

DAlessandro A, Zito F, Pesce M, Andreozzi P, Efficie E, Cargiolli M United European Gastroenterol J. 2017; 5(1):54-59.

PMID: 28405322 PMC: 5384555. DOI: 10.1177/2050640616650061.


Pathophysiology of functional heartburn based on Rome III criteria in Japanese patients.

Tamura Y, Funaki Y, Izawa S, Iida A, Yamaguchi Y, Adachi K World J Gastroenterol. 2015; 21(16):5009-16.

PMID: 25945016 PMC: 4408475. DOI: 10.3748/wjg.v21.i16.5009.


Comparison of gastroesophageal reflux disease symptoms and proton pump inhibitor response using gastroesophageal reflux disease impact scale questionnaire.

Jo S, Kim N, Lim J, Shin C, Park Y, Lee D J Neurogastroenterol Motil. 2013; 19(1):61-9.

PMID: 23350049 PMC: 3548129. DOI: 10.5056/jnm.2013.19.1.61.


The Therapeutic and Diagnostic Value of 2-week High Dose Proton Pump Inhibitor Treatment in Overlapping Non-erosive Gastroesophageal Reflux Disease and Functional Dyspepsia Patients.

Kriengkirakul C, Patcharatrakul T, Gonlachanvit S J Neurogastroenterol Motil. 2012; 18(2):174-80.

PMID: 22523726 PMC: 3325302. DOI: 10.5056/jnm.2012.18.2.174.


Overlap of dyspepsia and gastroesophageal reflux in the general population: one disease or distinct entities?.

Choung R, Locke 3rd G, Schleck C, Zinsmeister A, Talley N Neurogastroenterol Motil. 2011; 24(3):229-34, e106.

PMID: 22150874 PMC: 3589973. DOI: 10.1111/j.1365-2982.2011.01845.x.